|
|
|
|
|
Legal status
Patent expired
| (51) | INT.CL. | C07D 471/04 | (2006.01) |
| A61K 31/437 | (2006.01) | ||
| A61P 7/02 | (2006.01) | ||
| C07D 413/14 | (2006.01) |
| (11) | Number of the document | 1427415 |
| (13) | Kind of document | T |
| (96) | European patent application number | 02775843.2 |
| Date of filing the European patent application | 2002-09-17 | |
| (97) | Date of publication of the European application | 2004-06-16 |
| (45) | Date of publication and mention of the grant of the patent | 2009-08-12 |
| (46) | Date of publication of the claims translation | 2009-12-28 |
| (86) | Number | PCT/US2002/029491 |
| Date | 2002-09-17 |
| (87) | Number | WO 2003/026652 |
| Date | 2003-04-03 |
| (30) | Number | Date | Country code |
| 324165 P | 2001-09-21 | US |
| (72) |
PINTO, Donald, US
QUAN, Mimi, US
ORWAT, Michael, US
LI, Yun-Long, US
HAN, Wei, US
QIAO, Jennifer, X., US
LAM, Patrick, US
KOCH, Stephanie, US
|
| (73) |
Bristol-Myers Squibb Holdings Ireland Unlimited Company,
Hinterbergstrasse 16, 6312 Steinhausen,
CH
|
| (74) |
Marius JAKULIS - JASON,
AAA Law, A. Goštauto g. 40B, Verslo centras "Dvyniai", LT-03163 Vilnius,
LT
|
| (54) | Laktamą turintys junginiai ir jų dariniai kaip XA faktoriaus inhibitoriai |
| LACTAM-CONTAINING COMPOUNDS AND DERIVATIVES THEREOF AS FACTOR XA INHIBITORS |
| Payment date | Validity (years) | Amount | |
| 2021-08-19 | 347.00 EUR |